Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Relevance of the quantification of apolipoprotein E in the cerebrospinal fluid in Alzheimer's disease.

Neuroscience letters - 12 Jul 1996

Lefranc D, Vermersch P, Dallongeville J, Daems-Monpeurt C, Petit H, Delacourte A

Abstract excerpt

Apolipoprotein E (Apo E), one of the major structural and functional apolipoproteins, has recently been implicated in the pathogenesis of Alzheimer's disease (AD). Several studies revealed that Apo E4 isoform is associated with the pathogenic process in AD. A significant reduction of cerebrospinal fluid (CSF) Apo E level in AD patients has been reported in two studies. To further investigate the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Alleles
Share to Alzheimer Disease

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Apolipoproteins E

Share to Sex Factors

Source

Identifiers

PMID: 8832646
DOI: 10.1016/0304-3940(96)12774-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Relevance of the quantification of apolipoprotein E in the cerebrospinal fluid in Alzheimer's disease.PMID 8832646Read ↗

Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.Semantic proximity Read ↗

Cerebrospinal fluid apolipoprotein E level is increased in late-onset Alzheimer's disease.Semantic proximity Read ↗

Apolipoprotein E levels in the cerebrospinal fluid of north Indian patients with Alzheimer's disease.Semantic proximity Read ↗

Measurement of apolipoprotein E (apoE) in cerebrospinal fluid.Semantic proximity Read ↗

Apo-Eε4 allele in conjunction with Aβ42 and tau in CSF: biomarker for Alzheimer's disease.Semantic proximity Read ↗

Age-dependent decline in the apolipoprotein E level in cerebrospinal fluid from control subjects and its increase in cerebrospinal fluid from patients with Alzheimer's disease.Semantic proximity Read ↗

Assessment of apolipoprotein E genotype for β-amyloid status prediction.Semantic proximity Read ↗

Cerebrospinal fluid apo E and apo A-I concentrations in early- and late-onset Alzheimer's disease.Semantic proximity Read ↗

Apolipoprotein E in cerebrospinal fluid: relation to phenotype and plasma apolipoprotein E concentrations.Semantic proximity Read ↗

Apolipoprotein E in Cerebrospinal Fluid from Patients with Alzheimer's Disease and Other Forms of Dementia Is Reduced but without Any Correlation to the apoE4 IsoformSemantic proximity Read ↗

Cerebrospinal fluid levels of amyloid beta-protein in Alzheimer's disease: inverse correlation with severity of dementia and effect of apolipoprotein E genotype.Semantic proximity Read ↗

Reduced levels of cholesterol, phospholipids, and fatty acids in cerebrospinal fluid of Alzheimer disease patients are not related to apolipoprotein E4.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.